M. Schiffman and P. Castle, The Promise of Global Cervical-Cancer Prevention, New England Journal of Medicine, vol.353, issue.20, pp.2101-2104, 2005.
DOI : 10.1056/NEJMp058171

A. Guizard and B. Trétarre, Col de l'utérus Réseau français des registres de cancer, Hospices civils de Lyon, Inserm, Invs, eds Estimation de l'incidence et de la mortalité par cancer en France de, 1980.

D. Fernis and M. Litaker, ASCUS/LSIL Triage Study (ALTS) Group. Colposcopy quality control by remote review of digitized colposcopic images, Am J Obstet Gynecol, vol.191, issue.6, pp.1934-1975, 2004.

M. Nucci and C. Crum, Redefining Early Cervical Neoplasia: Recent Progress, Advances in Anatomic Pathology, vol.14, issue.1, pp.1-10, 2007.
DOI : 10.1097/PAP.0b013e31802e0de7

E. Curado, H. Shin, H. Storm, J. Ferlay, and M. Heanue, Cancer Incidence in Five Continents, IARC Scientific publications, 2007.

N. Duport and . De-veille-sanitaire, Données épidémiologiques sur le cancer du col de l'utérus. Etat des connaissances ? Actualisation, 2008.

L. Ries, D. Melbert, M. Krapcho, A. Mariotto, B. Miller et al., Bethesda: National Cancer Institute, Cancer Statistics Review, 1975.

A. Jemal, A. Thomas, T. Murray, and M. Thun, Cancer statistics CA: a cancer journal for clinicians, pp.23-47, 2002.

M. Arbyn, A. Raifu, P. Autier, and J. Ferlay, Burden of cervical cancer in Europe: estimates for 2004, Annals of Oncology, vol.18, issue.10, pp.1708-1723, 2004.
DOI : 10.1093/annonc/mdm079

A. Be1ot, P. Grosc1aude, N. Bossard, E. Joug1a, E. Benhamou et al., Cancer incidence and mortality in France over the period 1980-2005. Revue d'épidemiologie et de santé publique, pp.159-75, 2008.

V. Institut-de and . Sanitaire, Calendrier vaccinal 2009 selon l'avis du Haut conseil de la santé publique, pp.16-17, 2009.

J. Prétet, A. Jacquard, X. Carcopino, C. J. Bouhour, D. Kantelip et al., Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study, International Journal of Cancer, vol.367, issue.Suppl 3, pp.428-432, 2008.
DOI : 10.1016/S0140-6736(06)68439-0

J. Prétet, A. Jacquard, X. Carcopino, S. Monnier-benoit, G. Averous et al., Human papillomavirus genotype distribution in high grade cervical lesions

A. Jacquard, F. Denis, J. Prétet, F. Aubin, P. Pradat et al., Distribution des génotypes de papillomavirus humain (HPV) dans les lésions génitales en France : études EDITH, BEH, vol.29, pp.313-317, 2009.

R. Richart, A follow-up study of patients with cervical dysplasia, American Journal of Obstetrics and Gynecology, vol.105, issue.3, pp.186-192, 1969.
DOI : 10.1016/0002-9378(69)90268-3

P. Tranbaloc, Histoire naturelle des lésions précancéreuses du cancer du col utérin
DOI : 10.1016/j.gyobfe.2008.03.016

A. Ostor, Natural History of Cervical Intraepithelial Neoplasia, International Journal of Gynecological Pathology, vol.12, issue.2, pp.186-92, 1993.
DOI : 10.1097/00004347-199304000-00018

P. Castle, M. Stoler, D. Solomon, M. Schiffman, and . For, The Relationship of Community Biopsy-Diagnosed Cervical Intraepithelial Neoplasia Grade 2 to the Quality Control Pathology-Reviewed Diagnoses, American Journal of Clinical Pathology, vol.127, issue.5, pp.805-815, 2007.
DOI : 10.1309/PT3PNC1QL2F4D2VL

P. Castle, . Schiffmanm, C. Wheele, and D. Solomon, Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia???Grade 2, Obstetrics & Gynecology, vol.113, issue.1, pp.18-25, 2009.
DOI : 10.1097/AOG.0b013e31818f5008

H. Long, N. Laack, and B. Gostout, Prevention, Diagnosis, and Treatment of Cervical Cancer, Mayo Clinic Proceedings, vol.82, issue.12, pp.1566-1574, 2007.
DOI : 10.1016/S0025-6196(11)61104-X

F. Denis, S. Hanz, and A. S. , Clairance, persistance et r??cidive de l???infection ?? Papillomavirus, Gyn??cologie Obst??trique & Fertilit??, vol.36, issue.4, pp.430-440, 2008.
DOI : 10.1016/j.gyobfe.2008.02.008

S. Regauer and O. Reich, CK17 and p16 expression patterns distinguish (atypical) immature squasous metaplasia from high-grade cervical intraepithelial (CINIII)
DOI : 10.1111/j.1365-2559.2007.02652.x

URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2559.2007.02652.x/pdf

N. Mulvany, D. Allen, and S. Wilson, Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsies, Pathology, vol.40, issue.4, pp.335-379, 2008.
DOI : 10.1080/00313020802035907

M. Wicha, S. Liu, and G. Dontu, Cancer Stem Cells: An Old Idea???A Paradigm Shift, Cancer Research, vol.66, issue.4, pp.1883-1890, 2006.
DOI : 10.1158/0008-5472.CAN-05-3153

K. Mittal, Utility of Proliferation-Associated Marker MIB-1 in Evaluating Lesions of the Uterine Cervix, Advances in Anatomic Pathology, vol.6, issue.4, pp.177-85, 1999.
DOI : 10.1097/00125480-199907000-00001

J. Martens, F. Smedts, and R. Van-muyden, Reserve Cells in Human Uterine Cervical Epithelium Are Derived from M??llerian Epithelium at Midgestational Age, International Journal of Gynecological Pathology, vol.26, issue.4, pp.463-471, 2007.
DOI : 10.1097/pgp.0b013e31803c7c18

N. Bulkmans, J. Berkhof, and S. Bulk, High-risk HPV type-specific clearance rates in cervical screening, British Journal of Cancer, vol.10, issue.9, pp.1419-1443, 2007.
DOI : 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.3.CO;2-6

K. Syrjanen, Mechanisms and predictors of high-risk human papillomavirus (HPV) clearance in the uterine cervix, Eur J Gynaecol Oncol, vol.28, pp.337-51, 2007.

K. Syrjanen, Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papillomavirus (HPV), European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.65, issue.1, pp.45-53, 1996.
DOI : 10.1016/0028-2243(95)02303-A

J. Zavada, T. Kurosaki, A. Manetta, M. Berman, P. Disaia et al., A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN

M. Schiffman, H. Bauer, R. Hoover, A. Glass, D. Cadell et al., Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial Neoplasia, JNCI Journal of the National Cancer Institute, vol.85, issue.12, pp.958-64, 1993.
DOI : 10.1093/jnci/85.12.958

. Sahebali, Immunocytochemistry in liquid-based cervical cytology: Analysis of clinical use following a cross-sectional study, International Journal of Cancer, vol.35, issue.5, pp.1254-1260, 2006.
DOI : 10.1016/j.humpath.2003.08.028

F. Carozzi, M. Confortini, D. Palma, P. , D. Mistro et al., Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial, The Lancet Oncology, vol.9, issue.10, pp.937-982, 2008.
DOI : 10.1016/S1470-2045(08)70208-0

M. Huang, H. Li, X. Nie, X. Wu, and X. Jiang, An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions, Diagn Cytopathol, vol.38, issue.8, pp.573-581, 2010.

I. Tsoumpou, M. Arbyn, M. Kyrgiou, N. Wentzensen, G. Koliopoulos et al., p16INK4a immunostaining in cytological and histological specimens from the uterine cervix: A systematic review and meta-analysis, Cancer Treatment Reviews, vol.35, issue.3, 2009.
DOI : 10.1016/j.ctrv.2008.10.005

C. Bergeron, N. Wentzensen, C. F. , M. Doeberitz, and M. , La prot??ine p16INK4a : un marqueur cytologique pour d??tecter les n??oplasies intra??pith??liales de haut grade du col ut??rin, Annales de Pathologie, vol.26, issue.5, pp.397-402, 2006.
DOI : 10.1016/S0242-6498(06)70746-5

K. Sigurdsson and H. Sigvaldason, Is it rational to start population-based cervical cancer screening at or soon after age 20? Analysis of time trends in preinvasive and invasive diseases, European Journal of Cancer, vol.43, issue.4, pp.769-74, 2007.
DOI : 10.1016/j.ejca.2006.11.017

P. Martin-hirch, E. Paraskevaidis, and H. Kitchenner, Surgery for cervical intraepithelial neoplasia (Cochrane review). The Cochrane library, Issu 3 Oxfor: update Software, 2002.

W. Soutter, P. Sasieni, and T. Panoskalasia, Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia, International Journal of Cancer, vol.88, issue.8, pp.2048-55, 2006.
DOI : 10.1016/0090-8258(85)90271-9

I. Kalliala, A. Anttila, E. Pukkala, and P. Nieminen, Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study, BMJ, vol.331, issue.7526, pp.1183-1188, 2005.
DOI : 10.1136/bmj.38663.459039.7C

J. Melnikow, C. Mcgahan, G. Sawaya, T. Ehlen, and A. Colman, Cervical Intraepithelial Neoplasia Outcomes After Treatment: Long-term Follow-up From the British Columbia Cohort Study, JNCI Journal of the National Cancer Institute, vol.337, issue.sep18_1, pp.721-729, 2009.
DOI : 10.1136/bmj.a1284

A. Baloglu, D. Uysal, I. Bezircioglu, M. Bicer, and I. A. , Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions, Archives of Gynecology and Obstetrics, vol.127, issue.1, pp.69-73, 2010.
DOI : 10.1007/s00404-009-1298-3